| Abstrakt: |
Recently, several prognostic and predictive factors associated with the efficacy of neoadjuvant immunotherapy in NSCLC, such as tumor-intrinsic biomarkers, tumor microenvironment biomarkers, liquid biopsies, microbiota, metabolic profiles, and clinical characteristics, have been described. Keywords: Biomarkers; Cancer; Diagnostics and Screening; Drugs and Therapies; Health and Medicine; Immunotherapy; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology EN Biomarkers Cancer Diagnostics and Screening Drugs and Therapies Health and Medicine Immunotherapy Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology 1247 1247 1 05/29/23 20230530 NES 230530 2023 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Current study results on non-small cell lung cancer have been published. [Extracted from the article] |
